Mark V. Dahl
- Dermatology top 0.1%
- Epidemiology top 2%
- Pathology and Forensic Medicine top 1%
- Rheumatology top 1%
- Immunology top 5%
- Co-authors
- Richard B. OdomLynn A. DrakeFrank C. PowellJonathan K. WilkinMichael DetmarSergei A. GrandoAlvan R. FeinsteinDavid A. Kist
- Topics
- Autoimmune Bullous Skin Diseases (28 papers)Nail Diseases and Treatments (15 papers)Dermatology and Skin Diseases (15 papers)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
Mark V. Dahl
121 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Dermatology 2.1k
- Epidemiology 1.1k
- Pathology and Forensic Medicine 845
- Rheumatology 650
- Immunology 576
Countries citing papers authored by Mark V. Dahl
This map shows the geographic impact of Mark V. Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Dahl more than expected).
Fields of papers citing papers by Mark V. Dahl
This network shows the impact of papers produced by Mark V. Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Dahl. The network helps show where Mark V. Dahl may publish in the future.
Co-authorship network of co-authors of Mark V. Dahl
This figure shows the co-authorship network connecting the top 25 collaborators of Mark V. Dahl. A scholar is included among the top collaborators of Mark V. Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark V. Dahl. Mark V. Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 28 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 28 | |
| 6 | Building an OpenURL Resolver in Your Own Workshop. | 2 |
| 7 | 308 | |
| 8 | 128 | |
| 9 | Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosaceabreakdown → | 605 |
| 10 | 57 | |
| 11 | 11 | |
| 12 | 130 | |
| 13 | 9 | |
| 14 | 24 | |
| 15 | 12 | |
| 16 | 27 | |
| 17 | 224 | |
| 18 | 17 | |
| 19 | 128 | |
| 20 | 14 |
About Mark V. Dahl
Mark V. Dahl is a scholar working on Dermatology, Immunology and Allergy and Pathology and Forensic Medicine, having authored 124 papers that have together received 4.5k indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (28 papers), Nail Diseases and Treatments (15 papers) and Dermatology and Skin Diseases (15 papers). The work is most often cited by research in Dermatology (2.1k citations), Pathology and Forensic Medicine (845 citations) and Immunology and Allergy (265 citations). Mark V. Dahl has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Richard B. Odom, Lynn A. Drake, Frank C. Powell, Jonathan K. Wilkin, Michael Detmar, Sergei A. Grando, Alvan R. Feinstein, David A. Kist, Joel E. Bernstein and David R. Bickers. Their work appears in journals such as Journal of Clinical Investigation, Cancer and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.